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Abstract
Background: There is a longstanding concern about the accuracy of surrogate consent in representing the health care and
research preferences of those who lose their ability to decide for themselves. We sought informed, deliberative views of the
older general public ($50 years old) regarding their willingness to participate in dementia research and to grant leeway to
future surrogates to choose an option contrary to their stated wishes.
Methodology/Principal Findings: 503 persons aged 50+ recruited by random digit dialing were randomly assigned to one
of three groups: deliberation, education, or control. The deliberation group attended an all-day education/peer deliberation
session; the education group received written information only. Participants were surveyed at baseline, after the
deliberation session (or equivalent time), and one month after the session, regarding their willingness to participate in
dementia research and to give leeway to surrogates, regarding studies of varying risk-benefit profiles (a lumbar puncture
study, a drug randomized controlled trial, a vaccine randomized controlled trial, and an early phase gene transfer trial). At
baseline, 48% (gene transfer scenario) to 92% (drug RCT) were willing to participate in future dementia research. A majority
of respondents (57–71% depending on scenario) were willing to give leeway to future surrogate decision-makers.
Democratic deliberation increased willingness to participate in all scenarios, to grant leeway in 3 of 4 scenarios (lumbar
puncture, vaccine, and gene transfer), and to enroll loved ones in research in all scenarios. On average, respondents were
more willing to volunteer themselves for research than to enroll their loved ones.
Conclusions/Significance: Most people were willing to grant leeway to their surrogates, and this willingness was either
sustained or increased after democratic deliberation, suggesting that the attitude toward leeway is a reliable opinion.
Eliciting a person’s current preferences about future research participation should also involve eliciting his or her leeway
preferences.
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Introduction
Alzheimer’s disease (AD) is incurable, devastating, and highly
prevalent. The clinical research necessary to make progress against
AD, however, poses the dilemma of involving persons lacking the
capacity to provide informed consent. Although some persons with
mild AD may be able to provide consent, the disease leads to early
decisional incapacity [1,2,3], and surrogate consent for research is
usually necessary. But surrogate consent may be seen as
problematic–despite broad support for the practice of surrogate
consent for dementia research among the older general public and
caregivers of persons with AD [4,5,6]–because surrogates’
judgments about their loved ones’ preferences, both in the clinical
[7,8] and research settings [9,10], are often discordant. Further,
although surrogates might be helped by prior communication of
research participation preferences by their loved ones, most people
fail to communicate such preferences, even when they say they will
do so [11].
Pessimism about the accuracy of surrogate consent, however,
may need to be tempered by the evidence that most people do not
seem to value the concordance between their current preferences
and their future surrogates’ decisions as much as one might
assume. Studies have found that even when subjects voice a
preference regarding treatment [12,13,14] or research involve-
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ment [5,11,15,16] in the future, most are willing to grant at least
some leeway to their surrogates to override that stated preference.
However, most of these reports on persons’ willingness to grant
leeway in decision making regarding research are based on
traditional surveys (of selected populations from clinics, senior
centers, or ongoing research studies), in which the complex
scientific, legal, historical, and bioethical dimensions of the ethics
of dementia research–which are unfamiliar to most laypersons–are
not fully explained to the respondents. Given perennial concerns
about the concordance between a person’s current preferences and
future decisions by his or her surrogate and the implications of
leeway preferences for those concerns, optimizing the internal
validity of studies on respondents’ preferences regarding leeway is
important. In this paper, we report what happens to people’s
preferences regarding participation in dementia research and their
views on leeway when they receive in-depth, balanced information
and deliberate with peers in a day-long session dedicated to the
issue.
This report is part of a larger study whose primary focus was on
the impact of democratic deliberation on the older ($50 years old)
general public’s preferences regarding societal policy for address-
ing research with decisionally incapable elderly persons [6]. Here
we report the effect of deliberation on the older general public’s
willingness to participate in dementia research and to give leeway
to future surrogate decision-makers, i.e., their attitudes regarding
surrogate consent for dementia research from the perspective of
potential participants. We examine the predictors of willingness to
give at least some leeway to surrogates. In addition, we assessed
respondents’ willingness, as potential surrogates, to enroll a loved
one in research.
Methods
A detailed account of the theoretical basis and methodological
procedures for this study is available at http://tinyurl.com/DD-
methods-PDF [17,18].
Participants
Members of the older general public ($50 years old) within a
50-mile radius of Ann Arbor, Michigan were recruited through the
Survey Research Center of the Institute for Social Research (ISR)
at the University of Michigan via random-digit dialing (recruit-
ment flowchart available at http://tinyurl.com/DD-FlowChart).
Of 2402 eligible individuals contacted, 700 (29%) agreed to
participate in the study; of these, 503 (72%) completed the baseline
survey (Survey 1) and were randomized to one of three groups:
212 to a deliberative session group, 141 to an education group,
and 150 to a control group. Of those assigned to the deliberative
session, 160 (75%) attended an all-day education and deliberation
session. The education only group received by mail the annotated
slide presentations of the experts used in the deliberative session
(available at http://tinyurl.com/DD-Presentations). The control
group received surveys only, without any interventions.
Ethics Statement
This study was deemed exempt from review under the federal
regulations on human subjects research by the University of
Michigan’s Institutional Review Board.
Measures
The survey administered to subjects has been used in previous
studies to assess several aspects of attitudes toward surrogate
consent for dementia research [4,17]. It contains an introduction
to Alzheimer’s disease and to the ethical dilemma of involving
decisionally impaired subjects in research, and presents four
scenarios of approximately 120 words each describing hypothetical
research studies. The four scenarios depict: a study to develop a
diagnostic test requiring a lumbar puncture; a randomized
controlled trial for a new drug; a randomized controlled trial of
an AD vaccine; and an early-phase neurosurgical gene-transfer
trial.
In this paper, we focus on the following questions from the
survey: ‘‘Suppose you wanted to give a close family member
instructions for the future, in case you ever became unable to make
decisions for yourself. Would you say you would want to
participate in the study?’’ (We will refer to this as the ‘self-
perspective’ question). The response options were: definitely yes,
probably yes, probably not, and definitely not. The self-perspective
question was followed up with: ‘‘How much freedom or leeway
would you give the close family member to go against your
preference, and instead [opposite of stated preference: enroll/not
enroll you in the study]?’’ (leeway question) with response options
of no leeway, some leeway, or complete leeway. For how subjects
would choose if they were themselves acting as surrogates, we
asked: ‘‘Suppose you have a loved one who has Alzheimer’s
disease and cannot make decisions for him or herself. Would you
give permission for your loved one to be part of this study?’’ (We
will refer to this as the ‘surrogate perspective’ question). The
survey was written at an 8th-grade reading level (Flesch-Kincaid
grade level 8.4). For each question, subjects had an opportunity to
provide comments.
The survey was administered to each subject three times.
Survey 1 was administered by mail prior to randomization, about
one month before the deliberation date. Survey 2 was completed
at the end of the deliberation day (for the deliberation session
attendees) or around that date (by mail, for all others). Copies of
the deliberation day presentations (slides plus notes in Power-
PointH) were mailed to the education group with Survey 2. Survey
3 was sent by mail approximately 1 month after the deliberation
date.
Deliberation Session
On the day of the deliberation session, the attendees were
randomly assigned to tables, in groups of 5–7 persons per table.
The subjects were educated by experts in clinical research and in
bioethics, during a plenary session, using two 45-minute presen-
tations (followed by 15 minutes of Q&A): ‘‘Alzheimer’s Disease
Clinical Research’’ described features of Alzheimer’s disease,
current treatment, types of research on AD and treatment
development process, and how subjects are enrolled in research;
‘‘Ethical Issues in Surrogate-Based Research’’ described well-
known human subject abuses (including the Nazi experiments,
Tuskegee study, and Willowbrook), the resulting regulatory
process, the unsettled policy on surrogate consent, and the reasons
for and against surrogate consent for dementia research [17]. In
developing these presentations, the research team worked closely
with an advisory panel consisting of a political science expert in
deliberative democracy methods, a senior AD researcher, a
bioethicist-sociologist, a geriatrician, a director of a human subject
protections program at an academic medical center, a qualitative
research expert, a gerontological nurse, and a caregiver of a person
with AD. These presentations were further refined, based on a
final systematic review by the members of the advisory panel,
additional external experts (in both AD research and bioethics),
and laypersons [17]. Throughout the day, the subjects had
multiple opportunities to question the experts, and engaged in
three small-group deliberation sessions, moderated by a trained
facilitator [6].
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Analyses
The subjects’ responses to the three main questions [self-
perspective (willingness to participate), leeway (willingness to grant
leeway), and surrogate perspective (willingness to enroll a loved
one)] were compared across the three study groups to assess the
effects of democratic deliberation (DD) and education (i.e., via
written information) relative to the control condition. The analyses
were conducted separately for each of the 4 scenarios for each
study question. We used a generalized linear mixed-effects model
with subjects as random intercepts to adjust for within-subject
correlation in responses. The dependent variable was the change in
responses to the three main study questions, based on changes
from baseline (Survey 1, one month prior to DD session date) in
the responses at Survey 2 (just after DD session for DD group,
around that date for the rest) and at Survey 3 (approximately 1
month after DD session date). This variable’s value reflects
changes in the 4-point scale (definitely yes, probably yes, probably
no, definitely no) with a range of 23 to +3 for self-perspective and
surrogate perspective responses and changes in the 3-point scale
with a range from 22 to +2 for the leeway question (none, some
leeway, complete leeway), with positive changes indicating greater
willingness.
Each model included baseline values of the response, an
indicator of DD group at Survey 2 (i.e., an interaction of DD
group at Survey 2) and an indicator of education group at Survey
2 (i.e., an interaction of education group by Survey 2) to test for
DD and education effects relative to control group at Survey 2.
The model also included an indicator for Survey 3 for time effect
at one month after the DD session in the control group, an
indicator of DD group at Survey 3 to test for the DD effect relative
to control group at Survey 3, and similarly an indicator for
education group at Survey 3 to test for the education effect relative
to control group at Survey 3. The difference between DD and
education effects at each survey time was compared based on the
model as post-hoc tests. All analyses involving the deliberation
group conservatively included all those assigned to the deliberation
group (i.e., both deliberation session attendees and non-attendees).
In addition, for each of the 4 scenarios, differences in responses
to the ‘‘willingness to participate’’ (self-perspective) and ‘‘willing-
ness to enroll a loved one’’ (surrogate perspective) questions were
compared across the study groups and assessment times using a
generalized linear mixed effects model with the differences in
responses to the two questions as the dependent variable, with
subjects as random intercepts.
Lastly, we evaluated the predictors of willingness to give leeway
by using the baseline data (Survey 1) for the entire sample. For this
analysis, we constructed logistic regression models by dichotomiz-
ing the willingness to give leeway response (as complete/some
leeway vs. no leeway) because we wanted to assess the difference, if
any, between those who would not grant any leeway at all versus
others who would at least consider some leeway. The potential
predictors examined were gender, race, education level, financial
status, relationship to AD patient, marital status, and age, along
with responses from three different perspectives (responses to the
self-perspective and surrogate-perspective questions above, as well
as to the societal perspective question, ‘‘If patients cannot make
their own decisions about being in studies like this one, should our
society allow their families to make the decision in their place?’’) as
dichotomized variables (definitely/probably yes versus definitely/
probably no).
We also examined qualitative comments on the leeway question
for all three surveys. In all, there were 716 comments representing
222 different respondents. We grouped the comments by
participant ‘‘willingness to participate’’ (self-perspective dichoto-
mized as definitely or probably not willing vs. definitely or
probably willing) and ‘‘willingness to give leeway’’ (dichotomized
as no leeway vs. some/complete leeway). Two team members (SK,
KAR) independently read the comments to generate core themes
and categories. This coding scheme was iteratively refined by using
feedback from three coders (KAR and 2 research assistants). The
comments were coded using the final coding scheme by consensus
among the three coders. In the few instances where consensus
could not be reached (less than 1% of comments), the decision was
made by majority vote.
Results
Subject characteristics are summarized in Table 1. There were
no differences across the three arms (DD group, education-only
group, control group) in any of the participant characteristics
measured [6].
Baseline
For the overall sample at baseline (n = 503), 84% of subjects
responded that they were willing (41.2% definitely and 42.3%
probably) to participate in the lumbar puncture study, 92% in the
new drug RCT (48.9% definitely and 43.5% probably), 55% in
the vaccine study (16.7% definitely and 38.0% probably), and 48%
in the gene transfer study (11.9% definitely and 35.6% probably)
(See Figure S1). A majority of respondents at baseline were willing
to give some or complete leeway to a close family member to go
against their currently stated preferences regarding future research
participation: 69% for the lumbar puncture study (54.5% some
leeway and 14.5% complete leeway), 71% for the new drug RCT
(55.1% some, 15.5% complete), 61% for the vaccine study (52.3%
some, 9.1% complete), and 57% for the gene transfer study (47.3%
some, 9.7% complete). For those who were willing to participate in
research, 74–81% were willing to give leeway to a family member.
Even among those who were not willing to participate in future
research, 36–43% of respondents were still willing to give some or
complete leeway to family members to enroll them, depending on
the scenario.
The responses to all three willingness questions for all three
groups are presented in Tables S1 and S2. There were no
differences in the distribution of responses at baseline across the
three groups, except for the self-perspective response to the new
drug study scenario (x2 test, p = 0.04).
Attitudes Toward Participation in Research and Leeway
Table 2 gives the DD and education effect on attitudes toward
participating in research (self-perspective) for each scenario,
estimated using a linear mixed-effects model based on changes
in responses at Survey 2 and Survey 3 from Survey 1 (See Table
S1 for corresponding summary frequency data).
No education effect, compared with control group, was found in
the willingness to participate from self-perspective. However, in
each of four scenarios, there was a significant increase in
willingness to participate in the DD group immediately after the
deliberation compared to control group, and this change was
sustained after a month, as shown by a significant Survey 3 by DD
group interaction. For example, for the gene transfer scenario, the
DD effect compared to control group at Survey 2 was 0.21
(p = 0.03), and at Survey 3, the DD effect was even higher
(beta = 0.27; p = 0.004) compared with control group. Comparing
DD group versus education group parameter estimates showed a
difference for all scenarios except for the gene transfer scenario
(p,0.001 for lumbar puncture and new drug scenarios, p = 0.04
for vaccine scenario, p = 0.67 for gene therapy scenario). One
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month later, the DD effect remained significantly higher when
compared with the education group for all four scenarios
(p,0.001 for lumbar puncture, drug RCT, and vaccine scenarios
and p= 0.006 for gene transfer scenario).
For the leeway question (Table 3), the DD group became more
willing to give leeway for the lumbar puncture scenario
(beta = 0.15; p = 0.024) and for the vaccine scenario (beta = 0.17;
p = 0.016) after the deliberation session at Survey 2, and this effect
was sustained at 1 month for the lumbar puncture scenario.
The education group was not different from the control group
at either time point for any of the scenarios. The DD effects for the
lumbar puncture and vaccine scenarios at Survey 2 were not
Table 1. Participant characteristics at randomization, N = 503. (This table used with permission [6].)
DD (N=212) Education (N=141) Control (N=150) p-valuea
Female 127 (60) 94 (67) 96 (64) 0.42
Age in years (mean (SD))b 63 (8) 63 (9) 63 (10) 0.81
Marital status
Single 20 (10) 12 (9) 18 (12)
Married 132 (63) 87 (62) 85 (57)
Divorced 37 (18) 24 (17) 26 (17) 0.86
Widowed 21 (10) 18 (13) 20 (13)
Other 1 (1) 0 (0) 0 (0)
Hispanic or Latino/Latina 1 (1) 1 (1) 1 (1) 0.96
Race
White 183 (86) 125 (89) 127 (85)
Black or African-American 25 (12) 14 (10) 21 (14) 0.72
Other 4 (2) 2 (1) 1 (1)
Highest level of education
Less than BA 110 (52) 85 (60) 78 (52)
BA 54 (26) 35 (25) 41 (27) 0.39
More than BA 48 (23) 21 (15) 31 (21)
Finances at the end of a typical monthc
Some money left over 137 (65) 91 (65) 98 (65)
Just enough to make ends meet 54 (26) 35 (25) 35 (23) 0.99
Not enough to make ends meet 12 (6) 9 (6) 8 (5)
Relationship with an Alzheimer’s patient
Primary Caregiver/Decision-maker 56 (27) 41 (30) 34 (23)
Close to someone with AD 90 (43) 61 (44) 66 (44) 0.66
No relation 65 (31) 37 (27) 50 (33)
aBased on x2 tests, except for age which is based on ANOVA.
bAll cell values are N(%) except for age.
cSome percentages do not add to 100 because not all participants answered the question.
doi:10.1371/journal.pone.0054790.t001
Table 2. Linear mixed-effects model results of changes in responses to self-perspective question from Survey 1 (baseline),
adjusted for baseline responses.
Variables Lumbar Puncture New Drug RCT Vaccine Gene Transfer
Beta 95% CI p-value Beta 95% CI p-value Beta 95% CI p-value Beta 95% CI p-value
Survey 2*DDa .30 .17,.44 0.000 .23 .10, .36 0.001 .28 .10, .46 0.003 .21 .02, .39 0.029
Survey 2*Educationa .01 2.13,.15 0.888 2.03 2.17,.11 0.688 .08 2.11,.27 0.420 .17 2.03, .36 0.102
Survey 3b 2.08 2.19,.02 0.107 2.01 2.10,.09 0.887 .11 2.02,.24 0.086 .04 2.09, .18 0.550
Survey 3*DDc .26 .13,.40 0.000 .19 .06, .32 0.004 .21 .03, .39 0.020 .27 .09, .46 0.004
Survey 3*Educationc 2.01 2.16,.13 0.846 2.07 2.21, .06 0.287 2.12 2.31, .07 0.232 .01 2.19, .21 0.941
aEffect of democratic deliberation (DD) or education relative to control group at Survey 2 on attitudes toward participating in research (self-perspective).
bEffect of Survey 3 to Survey 2 in control group (i.e., time effect) on attitudes toward participating in research (self-perspective).
cEffect of democratic deliberation (DD) or education relative to control group at Survey 3 on attitudes toward participating in research (self-perspective).
doi:10.1371/journal.pone.0054790.t002
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significantly different when compared with the education group.
On the other hand, for the gene transfer study, while there was no
DD effect on leeway at Survey 2, the DD group expressed greater
willingness to give leeway after 1 month compared to the control
group (p= 0.007), and this delayed DD effect was significant even
when compared with the education group (p= 0.02).
Qualitative Responses
Among those who said they would give leeway (regardless of
whether they would be willing to participate or not), the main
reason they provided was that the surrogates would have more or
better information in the future: ‘‘There could be new info that
needs to be factored into decision making process’’ (Subject#353)
and ‘‘They could have new information that wasn’t available when
I gave instructions for the future’’ (S#266). For those who opted to
give leeway but had said ‘‘no’’ to participating in the study, they
noted in addition that the ratio of the risks/burdens vs. benefits
may be different at the time of the study or that the surrogates may
be able to better assess the risks at the time: ‘‘Possibly in the future
a safer and more effective vaccine will be developed’’ (S#312) and
‘‘Based on new finding for benefits & reduced risk’’ (S#668).
Those who would not give leeway tended to see leeway as
something that violated their right to make decisions for
themselves: ‘‘I feel very strongly that the choices I make about
my fate are mine and should not be changed’’(S#131). Those who
said ‘‘no’’ to both research participation and to leeway also
frequently emphasized the risk/burden or lack of direct benefit of
research as a reason for not allowing leeway. For example, one
participant commented regarding the vaccine scenario: ‘‘The
brain inflammation is the show stopper for me. While probably
severe at any age, I see it as life threatening for the elderly. It’s one
thing going into this trial without knowing particular risks. It’s
totally unacceptable to knowingly put people at risk’’ (S#016).
Attitude Toward Acting as a Surrogate
Table 4 presents the effect of DD and of education on
willingness to enroll a loved one in future research (surrogate
perspective) for each scenario at Survey 2 and at Survey 3. (The
corresponding summary data are presented in Table S2.).
Compared with the control group, the deliberation group
became more willing to enroll a loved one in research for all four
scenarios after the deliberation session, but the DD effect was not
significant for vaccine and gene therapy scenarios when compared
with the education group. On the other hand, changes in
surrogate perspective willingness were sustained 1 month later in
all four scenarios. Although the effect sizes were notably smaller
after one month compared with the effect size immediately after
the deliberation for the lumbar puncture, new drug and vaccine
study scenarios, the DD effect at one month was significant for all
four scenarios when compared with both control and education
groups. In the case of the education group, significant initial
changes (at Survey 2) were seen in their willingness to enroll a
loved one in the vaccine study and the gene transfer study;
however, these changes were not present after a month.
Respondents were more likely to participate themselves (self-
perspective) than to be willing to enroll a loved one (surrogate
perspective) for each of the four scenarios and across all three time
points. Averaged across the three survey times and across the three
study groups on the 4 point scale (definitely yes, probably yes,
probably no, definitely no) respondents were more willing to
participate themselves than to enroll a loved one for lumbar
puncture study by 0.27 points (p,0.001) for the lumbar puncture
study, by 0.22 points (p,0.001) for the new drug study, by 0.17
points (p,0.001) for vaccine study and by 0.18 points (p,0.001)
for gene transfer study.
Predictors of Leeway
At baseline (Survey 1), those willing to participate in future
research themselves were more willing to grant leeway to surrogate
decision-makers, even after controlling for willingness to allow a
societal policy of family surrogate consent and other participant
characteristics, for three scenarios (lumbar puncture, OR=2.75,
p = 0.01; vaccine RCT, OR=3.55, p,0.001; gene transfer,
OR=5.03, p,0.001, Table 5). Those who would allow a societal
policy of surrogate consent were more willing to grant leeway for
all scenarios (lumbar puncture, OR=2.05, p = 0.04; drug RCT,
OR=3.40, p = 0.005; vaccine RCT, OR=2.37, p = 0.001; gene
transfer, OR=3.87, p,0.001). Increasing age predicted willing-
ness to give leeway, but only in the two lower-risk scenarios
(lumbar puncture OR=1.03, p = 0.03; Drug RCT, OR=1.03,
p = 0.02). Those with greater than a bachelor’s degree were less
willing to give leeway than those with less than a bachelor’s degree
for the gene transfer scenario. Gender, race, financial status,
relationship to AD patient, marital status, and surrogate-perspec-
tive responses were not associated with willingness to allow leeway.
Table 3. Linear mixed-effects model results of changes in responses to leeway question from Survey 1 (baseline), adjusted for
baseline responses.
Variables Lumbar Puncture New Drug RCT Vaccine Gene Transfer
Beta 95% CI p-value Beta 95% CI p-value Beta 95% CI p-value Beta 95% CI p-value
Survey 2*DDa .15 .02, .29 0.024 .02 2.11, .15 0.793 .17 .03, .31 0.016 .05 2.09, .19 0.479
Survey 2*Educationa .07 2.07, .21 0.331 .00 2.14, .15 0.965 .08 2.07, .23 0.279 .02 2.13, .17 0.760
Survey 3b 2.04 2.14, .07 0.478 2.05 2.15, .06 0.406 .11 .01, .21 0.036 .00 2.11, .11 0.993
Survey 3*DDc .15 .01, .28 0.030 .07 2.06, .21 0.277 .08 2.05, .22 0.239 .19 .05, .33 0.007
Survey 3*Educationc .02 2.13, .16 0.814 2.02 2.16, .13 0.829 2.09 2.23, .06 0.251 .02 2.13, .17 0.797
aEffect of democratic deliberation (DD) or education relative to control group at Survey 2 on attitudes toward giving leeway to family member in making research
decisions if respondent is unable to make decision for self.
bEffect of Survey 3 to Survey 2 in control group (i.e., time effect) on attitudes toward giving leeway to family member in making research decisions if respondent is
unable to make decision for self.
cEffect of democratic deliberation (DD) or education relative to control group at Survey 3 on attitudes toward giving leeway to family member in making research
decisions if respondent is unable to make decision for self.
doi:10.1371/journal.pone.0054790.t003
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Discussion
There is a longstanding concern about the accuracy of surrogate
consent in representing the wishes of those who lose their ability to
decide for themselves [7,9,10]. But there is also evidence, both in
treatment [12,13,14] and research contexts [4,5,11,15,16], that
people are willing to grant their future surrogates leeway, even to
the point of surrogates going against their currently stated wishes.
Given that the concept of leeway challenges the traditional focus
on honoring stated preferences, it seems important to examine the
validity of leeway preferences, especially for surrogate consent for
research that has complex scientific, legal, historical, and
bioethical dimensions. We characterized the effect of democratic
deliberation on this willingness to grant leeway, and also compared
subjects’ responses given as potential future research subjects with
their responses given as surrogates for their loved ones.
We found that the DD group was more willing to give leeway
than controls for the lumbar puncture scenario (both immediately
after DD session and a month later), vaccine scenario (after DD
session but not sustained), and gene transfer scenario (one month
after DD session). Even for a high risk scenario such as gene
transfer, 71% were willing to give leeway to their future surrogates
a month after the DD session. These findings validate the overall
high rates of willingness to grant leeway found in traditional
surveys. The willingness to grant leeway to one’s future surrogates
appears to be a fairly robust phenomenon that needs to be
incorporated in debates about ethics of surrogate consent for
research. In particular, eliciting subject preferences regarding
participation in future dementia research, whether as part of a
research study (such as our study) or as part of a clinic’s practice in
eliciting advance preferences, should include questions about
leeway.
There were other notable findings about leeway preferences in
our study. At baseline prior to the deliberation session, a majority
of respondents (57%–71%, depending on scenario) were willing to
give some or complete leeway to a close family member to go
against their currently stated preferences about future dementia
research participation. This is consistent with prior studies which
found that senior center attendees were willing to grant leeway at
rates of 70% (lumbar puncture) and 81% (blood draw) [16], and a
national survey of older Americans using the same four scenarios
that found 55% to 67% of respondents willing to grant some or
complete leeway [5].
In terms of predictors of leeway responses, demographic
variables in general were not robust predictors. However,
willingness to volunteer for future dementia research and support
for a societal policy allowing familial surrogate consent for
dementia research were the strongest predictors of willingness to
give leeway. This finding is consistent with our previous national
survey study [5], and may reflect recognition on the part of people
willing to participate in research that there might be circumstances
in which a surrogate would deem enrollment unwise, and hence
they would allow a surrogate to act in a manner thought to be in
their best interests.
Table 4. Linear mixed-effects model results of changes in willingness to give permission for a loved one to participate in research
(surrogate perspective) from Survey 1 (baseline), adjusted for baseline responses.
Variables Lumbar Puncture New Drug RCT Vaccine Gene Transfer
Beta 95% CI p-value Beta 95% CI p-value Beta 95% CI p-value Beta 95% CI p-value
Survey 2*DDa .43 .29, .57 0.000 .29 .16, .42 0.000 .34 .17, .51 0.000 .19 .01, .36 0.038
Survey 2*Educationa .10 2.05, .26 0.188 .08 2.06, .22 0.264 .20 .01, .38 0.036 .25 .06, .43 0.010
Survey 3b .01 2.10, .12 0.904 .03 2.07, .14 0.523 .11 2.01, .24 0.066 .02 2.11, .15 0.723
Survey 3*DDc .21 .07, .35 0.004 .14 .01, .27 0.041 .21 .05, .38 0.013 .28 .10, .45 0.002
Survey 3*Educationc 2.05 2.21, .10 0.500 2.02 2.16, .12 0.791 2.06 2.24, .12 0.503 .09 2.10, .28 0.346
aEffect of democratic deliberation (DD) or education relative to control group at Survey 2 on willingness to give permission for a loved to participate in research.
bEffect of Survey 3 to Survey 2 in control group (i.e., time effect) on willingness to give permission for a loved to participate in research.
cEffect of democratic deliberation (DD) or education relative to control group at Survey 3 on willingness to give permission for a loved to participate in research.
doi:10.1371/journal.pone.0054790.t004
Table 5. Predictors of leeway responses at baseline.
Variables Lumbar Puncture New Drug Vaccine Gene Transfer
OR p-value 95% CI OR p-value 95% CI OR p-value 95% CI OR p-value 95% CI
Education level:
Bachelor’s Degree .69 0.139 .42–1.13 .81 0.415 .49–1.34 .80 0.389 .49–1.32 1.14 0.623 .68–1.89
.Bachelor’s Degree .77 0.341 .45–1.32 .92 0.774 .53–1.61 .79 0.404 .46–1.37 .49 0.014 .28–.86
Age 1.03 0.032 1.00–1.05 1.03 0.022 1.00–1.05 1.00 0.929 .98–1.02 1.00 0.720 .97–1.02
Self-perspective 2.75 0.011 1.26–6.00 1.90 0.205 .71–5.09 3.55 0.000 1.81–6.94 5.03 0.000 2.50–10.13
Societal perspective 2.05 0.037 1.04–4.04 3.40 0.005 1.46–7.91 2.37 0.001 1.42–3.94 3.87 0.000 2.24–6.67
Note: The model was also adjusted for gender, race, financial status, relationship to an Alzheimer’s patient, surrogate perspective response, and marital status. Reference
level for education level is less than bachelor’s degree. The self-perspective and societal perspective responses were dichotomized to willing and not willing (reference
level is ‘not willing’). OR = adjusted odds ratios.
doi:10.1371/journal.pone.0054790.t005
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Related to the previous point, it is notable that even among
respondents who stated that they were not willing to participate in
future dementia research at a point when they had lost capacity, a
significant minority (36–43% depending on scenario) stated that
they would be willing to give leeway to a surrogate decision-maker
to go against their currently stated preference. Taking this into
account (i.e., adding those who are willing to participate with those
who are not willing but are willing to grant leeway), the proportion
of potential research enrollees become significantly larger (66–
95% depending on scenario). This was most notable for the two
higher-risk scenarios of vaccine testing and gene transfer study.
For example, 47.5% said they were willing to participate in the
gene transfer scenario; an additional 18.5% said no, but were
willing to give leeway. This differential effect on higher risk
scenarios may reflect the fact that the lower risk scenarios tended
to have a ceiling effect. Further, content analysis of subjects’
comments shows that among those respondents who were willing
to give leeway, an important reason was that surrogates may have
more or better information in the future, implying both trust in
their surrogates as well as recognition of the uncertainties of
present preferences about future decisions. On the other hand,
those who were not willing to give leeway often saw the possibility
of going against their stated wishes as intrinsically wrong. Thus,
they considered the question of whether to allow leeway mostly as
a matter of principle rather than whether it would be desirable for
surrogates to have the flexibility to respond to situations that
cannot be anticipated at the time when an advance decision is
made.
We also found that the in-depth education and peer deliberation
involved in democratic deliberation had significant effects on
respondents’ willingness to participate in future dementia research.
The deliberation group became more willing than controls to
participate in all scenarios after deliberation, and this change was
sustained even after 1 month. Further, for all scenarios,
respondents were more willing to enroll themselves in research than
to enroll loved ones, suggesting a tendency to act in a protective
fashion as a surrogate.
The study has several limitations. First, among respondents
willing to grant leeway, there were many more respondents who
would grant only some leeway over complete leeway. As we did
not define ‘‘some leeway’’ or ‘‘complete leeway,’’ we need to be
cautious in our interpretation. Future research should attempt to
clarify the difference between the two response categories. Second,
although the internal validity of the study was high, external
validity may be limited by the considerable time commitment
required from volunteer participants for the deliberation sessions
and the consequent likelihood of self-selection. However, our
baseline results were similar to those found in a previous cross-
sectional study of the older general public ($50 years old),
providing some evidence that this group may not differ in
substantive attitudes toward surrogate consent compared to the
national sample [5]. Third, there may have been undetected group
dynamics or subtle influences from the experts during the
deliberation session that affected the deliberations. However,
careful qualitative analyses of the sessions show that the quality of
deliberation was quite high and that participants were very
satisfied with the sessions, learned and used new information, were
respectful and collaborative, and were able to ‘‘reason together’’
effectively [18]. Finally, because the attitudes elicited were based
upon information unique to dementia research, findings may not
be generalizable to other research, e.g., research involving
comatose subjects or incapacitated persons with mental illness.
In conclusion, most people in our study (like those in previous
studies of caregivers, [4] senior center attendees, [16] and the
older general public) were willing to grant leeway regarding
choices about research participation to their future surrogates–
even when leeway is explicitly defined as going against their stated
preferences. Further, this willingness is not an artifact of lack of
knowledge or deliberation, since in-depth education with peer
deliberation in fact tend to increase their willingness to grant such
leeway. It is also notable that a significant minority (36%–43%) of
our participants who said they would not want to volunteer for
research in case of future incapacity nonetheless was willing to
grant leeway. These results strongly suggest that a person’s current
preferences about future research participation are not the only–or
depending on the circumstances, even the most important–
legitimate basis for his or her future surrogate’s decisions.
Although a conventional bioethics framework may favor eliciting
and relying on statements of future preference [19], it appears that
most people are aware of future uncertainties and are open to the
idea that their surrogates might be in a better position to make
those decisions than they themselves are today.
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